Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Basia Rogula"'
Autor:
Nicolas Girard, Mariam Besada, Basia Rogula, Stefano Lucherini, Lien Vo, Mohammad A. Chaudhary, Sarah Goring, Greta Lozano-Ortega, Mia Tran, Nebibe Varol, Nathalie Waser, Jay M. Lee, Jonathan Spicer
Publikováno v:
Cancers, Vol 16, Iss 13, p 2492 (2024)
Background: This study aimed to estimate the relative efficacy of neoadjuvant nivolumab in combination with chemotherapy (neoNIVO + CT) compared to relevant treatments amongst resectable non-metastatic non-small-cell lung cancer (rNSCLC) patients. Me
Externí odkaz:
https://doaj.org/article/6e19752816b0486883be861758bb2cad
Publikováno v:
Health and Quality of Life Outcomes, Vol 21, Iss 1, Pp 1-10 (2023)
Abstract Background The North Star Ambulatory Assessment (NSAA) documents motor performance in ambulatory individuals with Duchenne muscular dystrophy (DMD). Health Utilities Index (HUI) scores, reflecting preferences for health-related quality-of-li
Externí odkaz:
https://doaj.org/article/d827b14871b44f358e99d3fe6e4f8dbc
Publikováno v:
Health and Quality of Life Outcomes, Vol 20, Iss 1, Pp 1-10 (2022)
Abstract Background Data on health state utility in Duchenne muscular dystrophy (DMD) are few. This study estimated mean utility values by age, ambulatory status and over time, and investigated which aspects of health-related quality-of-life (HRQoL)
Externí odkaz:
https://doaj.org/article/bafa14080e3b4effb5d8eda726d48656
Publikováno v:
MDM Policy & Practice, Vol 7 (2022)
Introduction. Access to individual patient data (IPD) can be advantageous when conducting cost-effectiveness analyses or indirect treatment comparisons. While exact times of censoring are often marked on published Kaplan-Meier (KM) curves, an algorit
Externí odkaz:
https://doaj.org/article/2f7db149144749d981b7c54b8da1b1a3
Autor:
Stephen R. Kraus, Amy Lockefeer, Greta Lozano-Ortega, Baoguo Jiang, Tomomi Kimura, Basia Rogula, Sally Miller, David Walker
Publikováno v:
Continence Reports. 5:100020
Autor:
Basia Rogula, Karissa Johnston, Carol R. Schermer, John Hairston, A. Mickle, Sean Harrigan, Greta Lozano-Ortega, Rita M Kristy, David Walker
Publikováno v:
Drugs & Aging. 37:801-816
Cumulative exposure to one or more anticholinergic medications (“anticholinergic burden”) is associated with an increased risk of adverse outcomes, particularly among older individuals. Mirabegron, an oral selective β3-adrenergic receptor agonis
Autor:
David Walker, Basia Rogula, Shelagh M. Szabo, Alison Deighton, Noll L. Campbell, Katherine Gooch, Carol R. Schermer, Greta Lozano-Ortega
Publikováno v:
PharmacoEconomics Open
Background Falls/fractures are major causes of morbidity and mortality among older adults and the resulting health consequences generate a substantial economic burden. Risk factors are numerous and include overactive bladder (OAB) and anticholinergic
Autor:
Adrian R Levy, Alexia Daoust, Basia Rogula, Paul Oh, Jonathan Fortier, Andrew Ignaszewski, Karissa Johnston
Publikováno v:
CMAJ Open
Background: Although the frequency of heart failure makes it among the costliest of illnesses, there are scant Canadian data on annual costs of treatment or the costs as the condition advances. Our objective was to estimate mean prevalence- and incid
Autor:
Greta Lozano-Ortega, David Walker, Alison Deighton, Neil Hawkins, Roger R. Dmochowski, Karissa Johnston, Basia Rogula
Publikováno v:
Urology. 127:1-8
OBJECTIVE To compare the efficacy and safety of mirabegron and onabotulinumtoxinA in the management of treatment-experienced patients with overactive bladder. METHODS The network meta-analysis was based on evidence from a systematic literature review
Autor:
Adrian Wagg, Basia Rogula, Daniel B. Ng, Noll L. Campbell, Brandon T. Suehs, Roger R. Dmochowski, Antoinette Cheung, Greta Lozano-Ortega, Shelagh M. Szabo, Eleanor O. Caplan
Publikováno v:
Advances in Therapy
Introduction As continuous exposure to anticholinergics has been associated with adverse outcomes, accurately measuring exposure is important. However, no gold standard measure is available, and the performance of existing measures has not been compa